DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,490,000 | -44.8% | 396,977 | -40.5% | 0.02% | -36.1% |
| Q2 2021 | $24,426,000 | -18.8% | 667,177 | -0.6% | 0.04% | -20.0% |
| Q1 2021 | $30,086,000 | -21.4% | 670,975 | 0.0% | 0.04% | -27.4% |
| Q4 2020 | $38,293,000 | +11.2% | 670,975 | 0.0% | 0.06% | -3.1% |
| Q3 2020 | $34,421,000 | -14.1% | 670,975 | 0.0% | 0.06% | -36.6% |
| Q2 2020 | $40,071,000 | +70.5% | 670,975 | +17.5% | 0.10% | +1.0% |
| Q1 2020 | $23,507,000 | -10.5% | 570,975 | +35.3% | 0.10% | +2.0% |
| Q4 2019 | $26,267,000 | -9.3% | 422,035 | -50.6% | 0.10% | -3.9% |
| Q3 2019 | $28,969,000 | +96.6% | 853,547 | +30.6% | 0.10% | +75.9% |
| Q2 2019 | $14,737,000 | -2.8% | 653,547 | 0.0% | 0.06% | -23.7% |
| Q1 2019 | $15,169,000 | +44.9% | 653,547 | +31.1% | 0.08% | +11.8% |
| Q4 2018 | $10,465,000 | -27.9% | 498,547 | +32.9% | 0.07% | -1.4% |
| Q3 2018 | $14,520,000 | – | 375,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |